ArticleBMC infectious diseases2025
Crowdsourcing strategies to improve access to HIV pre-exposure prophylaxis in Australia, the Philippines, Thailand and China.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Using Online Media to Increase the Awareness and Uptake of Preexposure Prophylaxis for HIV Among Asian-Born Men Who Have Sex With Men Living in Australia: An Open-Label Randomized Controlled Trial.Open forum infectious diseases · 2025Trial
- Ageing, health system implications, and a changing epidemic: organizational transitions and stigma dynamics in Philippine HIV care.Frontiers in public health · 2026Review
- Factors associated with HIV pre-exposure prophylaxis use among Asian men who have sex with men in Sydney and Melbourne, Australia: a cross-sectional study.The Lancet regional health. Western Pacific · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundMany Asian countries have yet to scale up HIV pre-exposure prophylaxis (PrEP). Crowdsourcing has a group of individuals solving a specific problem before sharing solutions with the public. This approach enhances community engagement and ownership of the solutions and can be used to generate culturally relevant solutions. We used crowdsourcing to seek innovative strategies to optimise PrEP access by increasing the uptake and effective use of PrEP. This study describes the experiences of crowdsourcing open calls in Australia, the Philippines, Thailand and China.
methodsFour crowdsourcing open calls were conducted between 2021-2023 in Australia, the Philippines, Thailand and China. All open calls entailed: 1) problem identification; 2) committee formation with local groups; 3) community engagement for idea submission (e.g., texts, posters, pitches); 4) evaluation of submissions; 5) awarding incentives to finalists; and 6) solution dissemination via web and social media. We reported the number of total and high-quality submissions. We also identified themes across countries.
resultsThe Australian, Filipino, Thai and Chinese teams received 9, 22, 9 and 19 eligible submissions, respectively. A total of 3, 10, 7 and 8 submissions had a mean score of 6/10 or greater. Three common solutions emerged across all the finalist ideas: enhanced service access, optimising promotional campaigns, and person-centred promotional materials. The winning ideas from the Australian, Filipino, Thai and Chinese teams were an anonymous online PrEP service, a printed ready-to-wear garment to create awareness about PrEP, PrEP and HIV self-testing kit dispensing kiosks and a poster on PrEP effectiveness, respectively.
conclusionsCrowdsourcing was a promising and versatile tool for developing PrEP strategies in the Asia-Pacific region. Further evaluations via clinical trials can bridge the gap between idea generation and implementation, creating the empirical evidence that is pivotal for the policy adoption of these innovations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.